Assessing the Impact of Inclisiran on LDL-C and PCSK9 Reduction in Hypercholesterolemic Patients: A Meta-analysis of Cardiovascular Metabolic Prevention
International Journal of the Cardiovascular Academy · 10.03.2026
DOI: 10.4274/ijca.2026.53315 ↗Kurz gefasst
Metaanalyse in der Zeitschrift International Journal of the Cardiovascular Academy, online erschienen am 10.03.2026. Verfasst von Agung Cendekia Putra Nusantara und 4 weiteren Autor:innen. Die Arbeit nennt 48 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Nusantara, A. C. P., Rapsanjani, A. D., Handirosiyanto, I., Mandiricha, T., & Gaffar, A. S. (2026). Assessing the Impact of Inclisiran on LDL-C and PCSK9 Reduction in Hypercholesterolemic Patients: A Meta-analysis of Cardiovascular Metabolic Prevention. International Journal of the Cardiovascular Academy. https://doi.org/10.4274/ijca.2026.53315
Vancouver
Nusantara ACP, Rapsanjani AD, Handirosiyanto I, Mandiricha T, Gaffar AS. Assessing the Impact of Inclisiran on LDL-C and PCSK9 Reduction in Hypercholesterolemic Patients: A Meta-analysis of Cardiovascular Metabolic Prevention. International Journal of the Cardiovascular Academy. 2026. doi:10.4274/ijca.2026.53315
BibTeX
@article{Nusantara2026,
author = {Nusantara, Agung Cendekia Putra and Rapsanjani, Ariella Diandihati and Handirosiyanto, Ikhwan and Mandiricha, Tara and Gaffar, Aisyah Silvia},
title = {Assessing the Impact of Inclisiran on LDL-C and PCSK9 Reduction in Hypercholesterolemic Patients: A Meta-analysis of Cardiovascular Metabolic Prevention},
journal = {International Journal of the Cardiovascular Academy},
year = {2026},
doi = {10.4274/ijca.2026.53315}
}
EUVIMED